Investor Relations Kit

The Regen Biologics Investor Relations (IR) Kit below provides all of the key IR information on the company, its products, and its market.  If you have any questions or require additional information, please call or email the ReGen IR department.

Investor Presentation
Financial Documents
Press Releases
Code of Ethics
Events and IR Presentations
IR Contacts

Financial documents are viewable in Acrobat format.  You must have version 3.01 or higher of the Adobe Acrobat Reader to view them. To obtain this latest version, click here.

The Menaflex™ (CMI) collagen scaffold is not cleared for sale in the U.S. and the Company makes no claim regarding its safety or efficacy for the U.S. market.